Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05032625 · ClinicalTrials.gov registry record

To Evaluate the Outcomes After Surgery for Necrotizing Soft Tissue Infections

A clinical trial, sponsored by New York Medical College.

Terminated
Registry status
13
Enrollment target

NCT05032625 is a clinical trial that was terminated before completion, run by New York Medical College. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05032625 was terminated before completion, sponsored by New York Medical College.

TERMINATED
Registry status
13 participants
Enrollment target

Study Summary

There is significant mortality associated with necrotizing soft tissue infections, it is imperative to decrease mortality and complications associated with this disease is determined. To accomplish this goal, study team will create a prospectively maintained database of all NSTI patients admitted at department of surgery. Investigators will asses the predictors of poor outcome and follow these patients for 1 year in clinic and asses the functional quality of life by incorporating 36-Item Short Form Survey (SF-36) score.

Interventions

  • PROCEDURE Surgery

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2019-07-01
Est. Completion 2020-09-01

Sponsor

New York Medical College

47 total trials

What the Registry Record Tells You About NCT05032625

The ClinicalTrials.gov registry entry for NCT05032625 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Medical College, which has 47 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Surgery is the first listed.

NCT05032625 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05032625 about?

NCT05032625 is a clinical study titled "To Evaluate the Outcomes After Surgery for Necrotizing Soft Tissue Infections". There is significant mortality associated with necrotizing soft tissue infections, it is imperative to decrease mortality and complications associated with this disease is determined. To accomplish this goal, study team will create a prospectively maintained database of all NSTI patients admitted at...

What is the current status of trial NCT05032625?

This trial is currently terminated. The enrollment target is 13 participants. The study started on 2019-07-01. Estimated completion is 2020-09-01.

What interventions are being tested in trial NCT05032625?

The interventions under investigation include: Surgery (PROCEDURE).

Who is sponsoring clinical trial NCT05032625?

This trial is sponsored by New York Medical College, which has 47 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.